PH94B Nasal Spray

DRUG2 trials

Sponsors

VistaGen Therapeutics, Inc.

Conditions

Social Anxiety Disorder

Phase 3

PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge

CompletedNCT04754802

VistaGen Therapeutics, Inc.Social Anxiety Disorder

Start: 2021-05-24End: 2022-06-22Updated: 2025-09-12

PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2

TerminatedNCT05011396

VistaGen Therapeutics, Inc.Social Anxiety Disorder

Start: 2021-08-30End: 2022-08-16Updated: 2025-11-24

Related Papers

Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder (SAD)

CNS Spectrums2024-10-01